
Photo Credit: Milton Levin/UConn
Scientific Frontline: Extended "At a Glance" Summary: Equine Leptospira Exposure
The Core Concept: A study revealing that over 60% of tested horses in Connecticut have been exposed to pathogenic Leptospira bacteria, the causative agent of the zoonotic disease leptospirosis.
Key Distinction/Mechanism: The study used serological testing to identify exposure to 40 different Leptospira strains. Unlike direct detection methods, this serological approach detects antibodies (antigens) indicating past exposure to the bacteria, though it cannot distinguish between antibodies generated from a natural infection versus those from vaccination.
Major Frameworks/Components:
- Zoonotic Transmission: Leptospira can infect both humans and animals. Horses can contract the bacteria from infected animals or contaminated environments (like stagnant water) and can shed it asymptomatically in their urine, facilitating environmental contamination and potential transmission to humans (though rare).
- Equine Health Impacts: Equine leptospirosis can cause severe reproductive issues (abortion, stillbirth, neonatal death, placentitis) and equine recurrent uveitis (ERU), also known as "moon blindness," a major cause of equine ocular pain and blindness.
- Serogroup Prevalence vs. Vaccine Coverage: The study found the most common serogroups to be Djasiman, Grippotyphosa, Australis, Pomona, and Icterohaemorrhagiae. Notably, the only available equine Leptospira vaccine targets the Pomona serogroup, which accounted for only 10% of the positive results in this study.
- One Health Concept: The research emphasizes the interconnectedness of human, environmental, and animal health, highlighting the need for comprehensive monitoring and biosecurity practices to manage disease spread.






.jpg)



.png)






.jpg)